MN

Mahesh Nanjibhai Pidhadiya

Active Director Director DIN 08772413
DIN 08772413 First appointment Mar 2021 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Mahesh Nanjibhai Pidhadiya

Data last updated:

Mahesh Nanjibhai Pidhadiya is a Director at Bhavani Interchem Private Limited (since 2021). The company operates in Pharma.

DIN 08772413
Primary Designation Director
Industry Pharma
First Appointment 08 Mar 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Bhavani Interchem Private Limited U24299GJ2021PTC120925
Director08 Mar 20212021Active

Board colleagues of Mahesh Nanjibhai Pidhadiya

Directorship timeline

Open interactive timeline →
Bhavani Interchem Private Limited
Premium access

Shareholding and investment profile for Mahesh Nanjibhai Pidhadiya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mahesh Nanjibhai Pidhadiya

Mahesh Nanjibhai Pidhadiya currently holds 1 directorship: Bhavani Interchem Private Limited (Director, since 08 Mar 2021).

Mahesh Nanjibhai Pidhadiya was first appointed on 08 Mar 2021 as Director at Bhavani Interchem Private Limited.

The current boards of Mahesh Nanjibhai Pidhadiya's companies include Jay Kumbhani (Bhavani Interchem Private Limited), Jayeshkumar Nanjibhai Pidhadiya (Bhavani Interchem Private Limited), Maheshbhai D Kumbhani (Bhavani Interchem Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available